Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 25, 2018 08:00 ET | Source: Insmed, Inc.

Insmed to Host First Quarter 2018 Financial Results Conference Call on Wednesday, May 2, 2018

BRIDGEWATER, N.J., April 25, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
March 29, 2018 08:00 ET | Source: Insmed, Inc.

Insmed Submits New Drug Application to FDA for ALIS in NTM Lung Disease Caused by MAC

ALIS previously designated as an orphan drug, breakthrough therapy and Qualified Infectious Disease Product (QIDP) BRIDGEWATER, N.J., March 29, 2018 (GLOBE NEWSWIRE) -- Insmed...
March 07, 2018 08:00 ET | Source: Insmed, Inc.

Insmed to Present at the Cowen and Company 38th Annual Health Care Conference

BRIDGEWATER, N.J., March 07, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
February 23, 2018 07:30 ET | Source: Insmed, Inc.

Insmed Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

On track to file NDA before the end of March and anticipate a priority reviewExtended amikacin liposome inhalation suspension (ALIS) intellectual property protection to 2035 with issuance of ninth...
February 21, 2018 17:26 ET | Source: Insmed, Inc.

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

BRIDGEWATER, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
February 20, 2018 08:00 ET | Source: Insmed, Inc.

Insmed Extends ALIS Intellectual Property Protection to 2035 with Issuance of Ninth U.S. Patent

BRIDGEWATER, N.J., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
February 15, 2018 08:00 ET | Source: Insmed, Inc.

Insmed to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call on Friday, February 23, 2018

BRIDGEWATER, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
February 07, 2018 16:30 ET | Source: Insmed, Inc.

Insmed to Present at the Leerink Partners 7th Annual Global Healthcare Conference

BRIDGEWATER, N.J., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
January 26, 2018 12:00 ET | Source: Insmed, Inc.

Insmed Announces Closing of Public Offering

BRIDGEWATER, N.J., Jan. 26, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM) announced the closing today of its previously announced public offering of its 1.75% convertible senior notes...
January 24, 2018 17:31 ET | Source: Insmed, Inc.

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

BRIDGEWATER, N.J., Jan. 24, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right